Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT03207347Phase 2Completed
A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)
CholangiocarcinomaMesotheliomaRenal Cell Carcinoma+1 more
PrincipalinvestigatorStart date: 2018-08-13

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

CholangiocarcinomaMesotheliomaCarcinoma, Renal Cell
Similarity Score15%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

CholangiocarcinomaCancer of Pancreas

Worked with same sponsors:

Bayer
Similarity Score10%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

MesotheliomaColorectal Cancer Metastatic
Similarity Score10%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Cancer of PancreasMesothelioma
Similarity Score10%

Saleh K Saleh, MD

Minia University

Related
23 trials

Shared therapeutic areas:

Cancer of PancreasCholangiocarcinoma
Similarity Score10%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

CholangiocarcinomaCancer of Pancreas
Similarity Score10%

Steven A. Rosenberg, MD, PhD

NCI - Surgery Branch

Related
29 trials

Shared therapeutic areas:

Uveal MelanomaCancer of Pancreas
Similarity Score10%

Tim F Greten, M.D.

National Cancer Institute (NCI)

Related
22 trials

Shared therapeutic areas:

CholangiocarcinomaCancer of Pancreas
Similarity Score10%

Salah-Eddin Al-Batran, Prof. Dr.

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Related
13 trials

Shared therapeutic areas:

CholangiocarcinomaCancer of Pancreas
Similarity Score10%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Cancer of PancreasMesothelioma
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03207347Phase 2PrincipalInvestigator

A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)

CholangiocarcinomaMesotheliomaRenal Cell Carcinoma+1 more
Completed
NCT01470417Phase 2PrincipalInvestigator

Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma

Pancreatic Cancer
Completed
NCT01471353Phase 2PrincipalInvestigator

Sorafenib Plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal Cancer

Colorectal Cancer Metastatic
Completed

All 3 trials loaded